H. Farmer

Effect of Telaprevir on the Pharmacokinetics of Midazolam and Digoxin

V. Garg, Katia Alves, G. Chandorkar, 2012, Journal of clinical pharmacology.

Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for Phase I clinical trial.

P. Hogg, G. Halbert, S. Ford, 2012, International journal of pharmaceutics.

Effects of omeprazole on plasma levels of raltegravir.

H. Teppler, J. Wagner, B. Nguyen, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

A. Harris, G. Parker, G. Jayson, 2013, Cancer Chemotherapy and Pharmacology.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Raymond L. Forbes, A. Astrup, F. Greenway, 2017, The Lancet.

Single therapeutic and supratherapeutic doses of anacetrapib, a cholesteryl ester transfer protein inhibitor, do not prolong the QTcF interval in healthy volunteers

J. Wagner, Yang Liu, A. Johnson‐Levonas, 2014, Journal of clinical pharmacology.